about
The Prodrug Approach: A Successful Tool for Improving Drug SolubilityGd-Complexes of New Arylpiperazinyl Conjugates of DTPA-Bis(amides): Synthesis, Characterization and Magnetic Relaxation Properties.Synthesis of mevalonate- and fluorinated mevalonate prodrugs and their in vitro human plasma stability.Structure-Activity Relationship for Thiirane-Based Gelatinase InhibitorsMatrix metalloproteinases in neuropathic pain and migraine: friends, enemies, and therapeutic targets.Acceleration of diabetic wound healing using a novel protease-anti-protease combination therapy.Water-soluble mmp-9 inhibitor prodrug generates active metabolites that cross the blood-brain barrierO-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.A chemical biological strategy to facilitate diabetic wound healing.Molecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects.Predicting the Enzymatic Hydrolysis Half-lives of New Chemicals Using Support Vector Regression Models Based on Stepwise Feature Elimination.Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury.Progress towards water-soluble triazole-based selective MMP-2 inhibitors.Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2).The thiirane-based selective MT1-MMP/MMP2 inhibitor ND-322 reduces melanoma tumor growth and delays metastatic dissemination.Inhibition of MMP-9 activity following hypoxic ischemia in the developing brain using a highly specific inhibitor.
P2860
Q26771271-4010154A-BD5E-456B-8E01-8A98B49F0A53Q30943652-4CBA98FD-1EDA-4B4D-9C03-60866E724F1AQ34921440-6C719440-FB4D-415D-B553-B23EB4DDB4E5Q36048569-F74ECD4A-16D2-490A-BB93-516AB0779B97Q36210614-A1E84624-A243-412F-83F2-90BA426F419EQ36371479-B50C0093-2516-4E04-A0C2-5F53F49B4C7BQ37113839-711A80A3-57B0-4866-AACA-7107B8B1EC9AQ37432524-12749E57-D43A-43B2-B85C-5C1260640A22Q37625582-6F7A1668-CA48-45B5-917C-F7D2B35376EEQ38093654-DC2E297C-BF00-4979-ABF3-A843338C63D8Q38719496-53B75320-09A2-4148-9329-D969BD5CE557Q38846432-FF81EF42-86F9-4D45-A2BC-E036FD34EADAQ39103154-259AED90-E282-49D6-9842-341745EDC576Q39197180-1AC637F9-FF0A-4684-8D32-0367F75038A2Q39336390-2E91DBB4-E8BD-44D6-B44F-CA1B2020A467Q48284943-639A51EB-2E50-4948-9CEE-BFBC0E8FA7F4
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Selective water-soluble gelatinase inhibitor prodrugs.
@ast
Selective water-soluble gelatinase inhibitor prodrugs.
@en
type
label
Selective water-soluble gelatinase inhibitor prodrugs.
@ast
Selective water-soluble gelatinase inhibitor prodrugs.
@en
prefLabel
Selective water-soluble gelatinase inhibitor prodrugs.
@ast
Selective water-soluble gelatinase inhibitor prodrugs.
@en
P2093
P2860
P356
P1476
Selective water-soluble gelatinase inhibitor prodrugs
@en
P2093
Major Gooyit
Masahiro Ikejiri
Mayland Chang
Mijoon Lee
Shahriar Mobashery
Valerie A Schroeder
P2860
P304
P356
10.1021/JM200566E
P407
P577
2011-09-06T00:00:00Z